榴莲视频

Oncology/Hematology >

Lung Cancer

News, opinions and meeting coverage in oncology/hematology.

A photo of a male Johnson & Johnson researcher writing chemical formulas on glass with a marker.

Industry Clinic 鈥� Ad Insights

What Will It Take to Deliver Both Health & Care in Oncology?

ASCO over a photo of McCormick Place in Chicago, IL

Limited-Stage SCLC Gets a New Standard of Care With Consolidation Durvalumab

Median OS was 55.9 months in the durvalumab group compared with 33.4 months in the placebo group

ASCO over a photo of McCormick Place in Chicago, IL

'Practice Changing' Trial for Inoperable Locally Advanced NSCLC

EGFR testing now needed for all patients with stage III disease, experts say

ASCO over a photo of McCormick Place in Chicago, IL

Virtual and In-Person Palliative Care Equally Beneficial in Advanced Lung Cancer

No differences observed in quality of life metric, patient and caregiver satisfaction

ASCO over a photo of McCormick Place in Chicago, IL

Subcutaneous Amivantamab Plus Lazertinib Non-Inferior to IV Dosing in NSCLC

Unexpectedly offers a possible overall survival benefit, researchers say

ASCO over a photo of McCormick Place in Chicago, IL

Novel Bispecific in EGFR-Mutant Lung Cancer Boosts PFS After Targeted Agents

China-based trial may present a hurdle to FDA approval, however

Onco Break over a computer rendering of a cancer cell.

Fewer Suicides in Cancer Patients; Circadian Rhythm Boost; HIV Vaccine for Cancer?

News, features, and commentary about cancer-related issues

ASCO over a photo of McCormick Place, in Chicago, IL

Unprecedented PFS Results in ALK-Positive Lung Cancer Trial

"We have not seen anything close to this," says expert

A close up photo of a man vaping.

Smoking Isn't the Only Source of Nicotine Addiction in Town

Emerging data suggest pharmacological interventions may help patients quit vaping

Onco Break over a computer rendering of a cancer cell.

Ignoring Colonoscopy Advice; Inflamed Tongue, Then Cancer; Acupuncture for Dry Mouth

News, features, and commentary about cancer-related issues

A close up photo of methylphenidate tablets.

Psychostimulant No Help in Relieving Cancer-Related Fatigue

No significant differences in outcomes between methylphenidate, placebo

Onco Break over a computer rendering of a cancer cell.

Cancer and Intimate-Care Products; Boost for CRC Stool Tests; Biopsy by Ultrasound?

News, features, and commentary about cancer-related issues

FDA APPROVED tarlatamab (Imdelltra) over a computer rendering of small cell lung cancer

FDA OKs Novel BiTE Agent for Small Cell Lung Cancer

First-in-class tarlatamab achieved a 40% ORR in previously treated extensive-stage SCLC

A photo of the vial and packaging of nivolumab (Opdivo) over a computer rendering of lung cancer.

Perioperative Nivolumab Boosts EFS in Resectable Lung Cancer

CheckMate 77T trial shows 42% reduction in risk of tumor recurrence, progression, or death

A photo of Dr. Laurie Margolies demonstrating the Koios DS Smart Ultrasound software

Will AI Replace Radiologists, or Just Make Them Better Than Ever?

Opinions differ on how much physicians should be embracing the technology

A computer rendering of KRAS G12C mutation in non-small cell lung cancer

Glecirasib Shows Promising Efficacy in KRAS-Mutated NSCLC

Trend towards better response rate, PFS compared with approved KRAS inhibitors

A photo of Environmental Protection Agency Administrator Michael Regan speaking at event at Howard University, in Washington.

EPA Bans Consumer Use of Toxic Chemical Known to Cause Liver, Lung Cancers

Methylene chloride has killed at least 88 workers since 1980

A menthol cigarette in an ashtray.

White House Indefinitely Delays Plan to Ban Menthol Cigarettes

Biden administration has delayed the final rule several times recently

Onco Break over a computer rendering of a cancer cell.

Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests

News, features, and commentary about cancer-related issues

FDA APPROVED alectinib (Alecensa) over a computer rendering of lung cancer.

Alectinib Lands FDA Approval for Adjuvant Therapy in NSCLC

The ALK inhibitor reduced the risk of recurrence or death by 76% versus chemotherapy

Onco Break over a computer rendering of a cancer cell.

Riding the 'Boob Bus'; Prior Authorization Pushback; Cancer Warning for Alcohol?

News, features, and commentary about cancer-related issues

AACR over a photo of San Diego Convention Center in San Diego, CA

Accelerated Aging Linked to Recent Increase in Early-Onset Solid Tumors

Strength of association increased in more recent birth cohorts

AACR over a photo of San Diego Convention Center in San Diego, CA

Can Late-Stage Cancer Incidence Serve as an Endpoint for Screening Trials?

Study shows it may be an alternative to cancer-specific mortality for some cancers, but not all

FDA APPROVED trastuzumab deruxtecan (Enhertu) over a computer rendering of antibodies attacking cancer cells

Enhertu Gets Tumor-Agnostic FDA Approval for HER2-Positive Cancers

About half of patients responded, duration of response as long as 19 months in three trials

Onco Break over a computer rendering of a cancer cell.

Cancer 'Tidal Wave' Forecast; Not Decaf, Too! Cautionary Tales of Cancer, Cannabis

News, features, and commentary about cancer-related issues

Photo of a man with a cigarette

Forget 'Pack-Years' for Lung Cancer Screening Eligibility, Study Suggests

Switching to just a 20-year duration of smoking could catch more cancers, eliminate disparities

Onco Break over a computer rendering of a cancer cell.

Chemo and Heart Disease; Flawed Lung Cancer Screening; New Vax Recommendations

News, features, and commentary about cancer-related issues

A photo of proposed cigarette warning labels.

Graphic Images on Cigarettes of Smoking's Harm Are Constitutional, Court Rules

Partial victory for federal regulators seeking to toughen warning labels

Onco Break over a computer rendering of a cancer cell.

Broader Cancer Risk With CAR-T? AI for Physician Burnout; 'Lollipops' ID Oral Cancer

News, features, and commentary about cancer-related issues

A photo of Asbestos Removal Technologies Inc. staff working to remove asbestos from a home in Howell, Michigan.

EPA Bans Asbestos, a Deadly Carcinogen Still in Use Decades After Partial Ban

New rule would prohibit chrysotile asbestos

A photo of a senior man receiving chemotherapy.

First-Line Immunotherapy Alone Sufficient for Older NSCLC Patients, Study Suggests

Retrospective analysis finds similar OS, PFS whether or not patients also received chemotherapy

Onco Break over a computer rendering of a cancer cell.

A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu

News, features, and commentary about cancer-related issues

FDA APPROVED amivantamab (Rybrevant) over a computer rendering of lung cancer.

FDA OKs Amivantamab as First-Line Lung Cancer Treatment

Bispecific drug lands full approval for NSCLCs with EGFR exon 20 insertion mutations

A photo of surgeons performing surgery on a patient with lung cancer

Changing the Surgical Paradigm in Oligometastatic NSCLC

Propensity-score matched analysis suggests survival benefit with surgery to the primary tumor

Onco Break over a computer rendering of a cancer cell.

Transforming Shots Into Pills; 'Tip of the Iceberg' for TILs? Food Additives Warning

News, features, and commentary about cancer-related issues

A computer rendering of a cancer cell in the bloodstream.

Another COVID Toll: Over 134,000 Undiagnosed Cancers During Height of Pandemic

Diagnosis rates remained low throughout 2020, with mortality increase projected

A medical illustration of pleural mesothelioma

Arginine Starvation Boosts OS in Mesothelioma

With frontline immunotherapy now standard, strategy could potentially find home in second-line

An MRI image of lung cancer.

Perioperative Tislelizumab Demonstrates Survival Benefit in NSCLC

But how well will the results from China translate to Western populations?

Onco Break over a computer rendering of a cancer cell.

Rush to Publish? Medicare Drug Plan Lawsuit Quashed; Activity Curbs Cancer Pain

News, features, and commentary about cancer-related issues

FDA APPROVED tepotinib (Tepmetko) over a computer rendering of a transparent body with lung cancer highlighted.

Tepotinib Gains Full Approval for Metastatic NSCLC

Agency converts accelerated approval for subset with MET exon 14 mutations

2

鈥�